SHP-1 alleviates acute liver injury caused by Escherichia coli sepsis through negatively regulating the canonical and non-canonical NFκB signaling pathways.

MLA

Wang, Ningning, et al. “SHP-1 Alleviates Acute Liver Injury Caused by Escherichia Coli Sepsis through Negatively Regulating the Canonical and Non-Canonical NFκB Signaling Pathways.” International Immunopharmacology, vol. 143, no. Pt 1, Dec. 2024, p. 113371. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.113371.

APA

Wang, N., Tan, S., Liu, H., Wang, M., Xia, J., Zhang, W., Wang, M., Liu, H., & Sha, Z. (2024). SHP-1 alleviates acute liver injury caused by Escherichia coli sepsis through negatively regulating the canonical and non-canonical NFκB signaling pathways. International Immunopharmacology, 143(Pt 1), 113371. https://doi.org/10.1016/j.intimp.2024.113371

Chicago

Wang, Ningning, Suxu Tan, Hongning Liu, Muyuan Wang, Jinqi Xia, Weijun Zhang, Minmin Wang, Hui Liu, and Zhenxia Sha. 2024. “SHP-1 Alleviates Acute Liver Injury Caused by Escherichia Coli Sepsis through Negatively Regulating the Canonical and Non-Canonical NFκB Signaling Pathways.” International Immunopharmacology 143 (Pt 1): 113371. doi:10.1016/j.intimp.2024.113371.